Metformin is one of those medicines that can quietly become part of everyday life.
A tablet after breakfast. Another with dinner. Months turn into years. If blood sugar remains reasonably controlled, it is easy to stop thinking about the medicine itself.
That may be a mistake, particularly as we grow older.
Metformin remains an important and widely used treatment for type 2 diabetes. Doctors have decades of experience with it, and when used on its own it has a relatively low risk of causing hypoglycaemia. The American Diabetes Association’s 2026 guidance for older adults continues to describe metformin as a useful glucose-lowering option for many older people.
But long experience with a medicine does not mean we should stop monitoring it. For somebody who has taken metformin for years, the better question is not simply, “Is metformin safe?” It is: What should my doctor and I continue checking as I get older?
The First Thing I Would Check: Vitamin B12
Metformin can reduce vitamin B12 levels. This is not merely a theoretical association. A long-term randomized trial published in The BMJ found lower B12 concentrations and a greater risk of biochemical B12 deficiency among people receiving metformin.
The problem is particularly relevant because B12 deficiency can be easy to overlook. Tiredness may be blamed on age. Tingling or numbness may be attributed to diabetic neuropathy. Weakness can have many explanations. Anaemia may develop gradually.
I have written separately about vitamin B12 deficiency in ageing, including why neurological symptoms and medication-related risk deserve attention. For long-term metformin users, that connection is especially important.
The 2026 ADA guidance for older adults recommends annual B12 monitoring in older adults who have been taking metformin for more than four years. The UK’s Medicines and Healthcare products Regulatory Agency also advises testing when deficiency is suspected and considering periodic monitoring in people with risk factors.
Finding low B12 does not automatically mean a patient should stop metformin. The deficiency can usually be investigated and treated while the diabetes regimen is reviewed separately by the treating clinician.
Kidney Function Matters More as We Age
Metformin leaves the body largely through the kidneys. That makes kidney function an important part of safe prescribing.
Doctors commonly assess kidney function using estimated glomerular filtration rate, or eGFR. According to the 2026 ADA guidance for older adults, metformin can generally be used when eGFR is 30 mL/min/1.73 m² or higher, with lower dosing appropriate when eGFR is between 30 and 45. Metformin should not be used below the recommended kidney-function threshold.
This does not mean everyone approaching an eGFR of 45 must suddenly stop taking it. It means the prescription needs more careful assessment. Kidney function can change with age and illness. A dose that was appropriate years ago may need reconsideration later.
The Rare Risk That Gets the Most Attention
Lactic acidosis is probably the metformin complication that frightens patients most when they read about it online. It is serious. It is also rare.
The useful question is therefore not whether the risk exists, but when that risk becomes more important. Advanced kidney impairment is one concern. Severe illness involving hypoxia or poor tissue perfusion can also change the risk assessment.
A clinician may temporarily stop metformin during a serious acute illness, hospitalization or in connection with certain procedures involving iodinated contrast. That does not necessarily mean the medicine has suddenly become dangerous. The patient’s circumstances have changed. Once the acute problem resolves and kidney function is satisfactory, the clinician can decide whether treatment should be restarted.
Diarrhoea and Stomach Problems Are Much More Common
For most people, the problem they are more likely to encounter is far less dramatic. The stomach complains.
Diarrhoea, nausea, abdominal discomfort and bloating are well-established adverse effects of metformin. Many people tolerate it perfectly well, while symptoms can be more noticeable when treatment begins or the dose increases.
Slow dose escalation can help. Extended-release metformin is another option doctors may consider when gastrointestinal tolerance becomes difficult. It would be too simplistic, however, to promise that changing formulations will eliminate every symptom.
Persistent diarrhoea should not simply be tolerated for months because “metformin always does this.” It deserves discussion with a doctor. There may be another cause, or the dose or formulation may need reconsideration.
Appetite Deserves Attention in Older Adults
Metformin can reduce appetite. For an overweight younger adult, modest appetite reduction may not sound concerning. The calculation can change in an older person who is already losing weight, eating poorly or becoming frail.
Unintentional weight loss in later life should not automatically be celebrated simply because someone has diabetes. Muscle mass matters. Nutrition matters. The ADA notes that appetite reduction from metformin can become problematic in some older adults.
This is a good example of why diabetes treatment cannot be reduced to one glucose number. Treatment has to fit the person.
What About Hypoglycaemia?
Metformin has an important advantage here. When taken by itself, it carries a low risk of hypoglycaemia.
Many people with type 2 diabetes do not take metformin alone. They may also use insulin or another glucose-lowering medicine. In that situation, a low glucose reading cannot automatically be blamed on metformin. The entire medication regimen needs to be examined.
What I Would Remove From My 2023 Article
Looking back at older health writing is useful because medical evidence forces a writer to be humble.
Some claims in my 2023 discussion of metformin were too broad. I mentioned anxiety, depression and muscular pain among possible long-term problems without giving readers enough evidence or context. I would not present those today as established routine long-term adverse effects of metformin.
That does not mean a person experiencing muscle pain, mood changes or other unexplained symptoms should ignore them. It means we should not automatically attribute such symptoms to metformin without evidence.
Five Conversations Worth Having With Your Doctor
If you have been taking metformin for years, you do not need to become frightened of the medicine. You need better questions.
- When was my kidney function last checked, and what is my eGFR?
- If I have used metformin for several years, should my vitamin B12 be measured?
- Could persistent diarrhoea, nausea or loss of appetite be related to my treatment?
- What should I do with metformin if I become seriously ill, dehydrated or am admitted to hospital?
- Is my current dose and overall diabetes regimen still appropriate for me now?
That last question becomes more useful with age. A prescription should not remain unchanged merely because it has remained unchanged for years.
Metformin Is Not the Enemy
Updating this article has changed the way I would frame the subject. The interesting story is not that metformin has frightening hidden dangers. It doesn’t need that headline.
The more useful story is that a familiar medicine still deserves attention after years of use. For many older adults with type 2 diabetes, metformin remains useful. Its low risk of hypoglycaemia is valuable. Decades of clinical experience also mean doctors understand its benefits and limitations unusually well.
But ageing changes the patient even when the medicine remains the same. Kidney function can decline. Nutrition can change. Other medicines accumulate on the prescription. B12 levels may fall quietly.
Do not stop metformin because you are worried about its long-term effects. Make sure its long-term effects are actually being monitored.
Medical note: This article is for general health education and does not replace individual medical advice. Do not start, stop or change prescribed medication without consulting an appropriate healthcare professional.